Peripheral Nerve Stimulators (PNS) Market Size 2024-32 Share, Industry Research Report

(MENAFN- Meridian market Consultants) The Reports and Insights, a leading market research company, has recently releases report titled “Peripheral Nerve Stimulators (PNS) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2031.” The study provides a detailed analysis of the industry, including the global Peripheral Nerve Stimulators (PNS) Market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights:

How big is the Peripheral Nerve Stimulators (PNS) Market?

The global peripheral nerve stimulators (PNS) market was US$ 0.64 Billion in 2022. Furthermore, the global peripheral nerve stimulators (PNS) market to register a CAGR of 5.9 % which is expected to result in a market forecast value for 2031 of US$ 1.07 Billion.

What are Peripheral Nerve Stimulators (PNS)?

Peripheral Nerve Stimulators (PNS) represent medical devices crafted to administer controlled electrical stimulation to peripheral nerves, those situated outside the central nervous system encompassing the brain and spinal cord. The primary objective of these devices is therapeutic, serving to address various medical conditions. Specifically, PNS finds application in pain management, the treatment of specific neurological disorders, and assistance in the rehabilitation of muscles. The fundamental mechanism involves the delivery of electrical impulses to targeted peripheral nerves. Through this process, PNS has the capability to modulate nerve activity, exerting an influence on the transmission of pain signals within the nervous system.

Request for a sample copy with detail analysis: 

What are the growth prospects and trends in the Peripheral Nerve Stimulators (PNS) industry?

The peripheral nerve stimulators (PNS) market growth is on a notable upswing, propelled by the increasing prevalence of chronic pain conditions, neurological disorders, and the broader adoption of neuromodulation therapies. These medical devices, designed to administer controlled electrical stimulation to peripheral nerves, are gaining prominence for their effectiveness in pain management and rehabilitation. The market is witnessing a transition towards advanced implantable PNS technologies that offer customizable parameters to tailor treatments for individual patients. Additionally, growing awareness of non-opioid pain management alternatives is contributing to the peripheral nerve stimulators (PNS) market growth. With ongoing technological advancements and a rising aging population, the PNS market is poised for sustained growth, fostering collaborations between healthcare providers and device manufacturers to elevate patient outcomes.

What is included in market segmentation?

The report has segmented the market into the following categories:

Product Type:

Implantable Peripheral Nerve Stimulators
External Peripheral Nerve Stimulator

Application:

Chronic Pain Management
Neurological Disorders
Musculoskeletal Disorders
Others

End-User:

Hospitals
Ambulatory Surgical Centers
Pain Management Clinics
Rehabilitation Centers
Others

Technology:

Electrical Stimulation
Pulsed Radiofrequency
Transcutaneous Electrical Nerve Stimulation (TENS)
Others

Mode of Purchase:

Disposable Devices
Rechargeable Devices

North America:

United States
Canada

Europe:

Germany
United Kingdom
France
Italy
Spain
Russia
Poland
BENELUX
NORDIC
Rest of Europe

Asia Pacific:

China
Japan
India
South Korea
ASEAN
Australia & New Zealand
Rest of Asia Pacific

Latin America:

Brazil
Mexico
Argentina
Rest of Latin America

Middle East & Africa:

Saudi Arabia
South Africa
United Arab Emirates
Israel
Rest of MEA

Who are the key players operating in the industry?

The report covers the major market players including:

Medtronic
Abbott Laboratories
Boston Scientific Corporation
Nevro Corp
Nuvectra Corporation
Stimwave Technologies
Bioness Inc.
Soterix Medical Inc.
Synapse Biomedical Inc.
SPR Therapeutics
BioMedical Design Inc.
NeuroSigma Inc.
Neuronetics Inc.
Saluda Medical Pty Ltd.
St. Jude Medical Inc. (now part of Abbott Laboratories)

View Full Report:

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

Reports and Insights consistently mееt international benchmarks in the market research industry and maintain a kееn focus on providing only the highest quality of reports and analysis outlooks across markets, industries, domains, sectors, and verticals. We have bееn catering to varying market nееds and do not compromise on quality and research efforts in our objective to deliver only the very best to our clients globally.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

MENAFN18012024004629010566ID1107738152